|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/397 | |
| A61P 25/28 |
| (11) | Number of the document | 1392287 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02774113.1 |
| Date of filing the European patent application | 2002-05-22 | |
| (97) | Date of publication of the European application | 2004-03-03 |
| (45) | Date of publication and mention of the grant of the patent | 2006-11-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2002/016306 |
| Date | 2002-05-22 |
| (87) | Number | WO 2002/096415 |
| Date | 2002-12-05 |
| (30) | Number | Date | Country code |
| 293651 P | 2001-05-25 | US | |
| 323911 P | 2001-09-21 | US |
| (72) |
DAVIS, Harry, R., US
PARKER, Eric, McFee, US
VAN HEEK, Margaret, US
WONG, Gwendolyn, Tse, US
MERKEL, Laura, B., US
|
| (73) |
Schering Corporation,
2000 Galloping Hill Road, Kenilworth, NJ 07033-0530,
US
|
| (54) | Use of substituted azetidinone derivatives in the treatment of Alzheimer`s disease |
| Use of substituted azetidinone derivatives in the treatment of Alzheimer`s disease |